Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?
| Publicado en: | European Journal of Nuclear Medicine & Molecular Imaging Vol. 39; no. 3; pp. 446 - 450 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Mar2012
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=104327237&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 104327237 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 16197070 NPC jtl: European Journal of Nuclear Medicine & Molecular Imaging issn: 16197070 maglogo: N pubinfo: dt: Mar2012 vid: 39 iid: 3 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 104327237 2011948494 10.1007/s00259-011-2018-3 104327237 ppf: 446 ppct: 4 formats: fmt: @attributes: type: P tig: atl: Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients? aug: au: Evangelista, Laura Rubello, Domenico Saladini, Giorgio affil: Radiotherapy and Nuclear Medicine Unit, Istituto Oncologico Veneto (IOV - IRCCS), Via Gattamelata, 64 35128 Padova Italy sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|